CPDA-1 Blood Collection System
CPDA-1 Blood Collection Set with Sampling System
Approved
Approval ID
949abd84-24b2-4e38-8640-12073408d46b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 27, 2023
Manufacturers
FDA
Haemonetics Corporation
DUNS: 057827420
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Blood Collection System
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code53157-730
Application NumberBN800077
Product Classification
M
Marketing Category
C73594
G
Generic Name
Blood Collection System
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 27, 2023
FDA Product Classification
INGREDIENTS (5)
SODIUM CITRATEActive
Quantity: 1.66 g in 63 mL
Code: 1Q73Q2JULR
Classification: ACTIB
DEXTROSE MONOHYDRATEActive
Quantity: 2.01 g in 63 mL
Code: LX22YL083G
Classification: ACTIB
CITRIC ACID MONOHYDRATEActive
Quantity: 0.206 g in 63 mL
Code: 2968PHW8QP
Classification: ACTIM
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEActive
Quantity: 0.14 g in 63 mL
Code: 593YOG76RN
Classification: ACTIB
ADENINEActive
Quantity: 0.017 g in 63 mL
Code: JAC85A2161
Classification: ACTIB